Cloning and characterization of the antiviral activity of feline Tetherin/BST-2
about
Vpu and BST2: Still Not There Yet?Identification and functional analysis of three isoforms of bovine BST-2Antiviral potency and functional analysis of tetherin orthologues encoded by horse and donkey.Epitope tags beside the N-terminal cytoplasmic tail of human BST-2 alter its intracellular trafficking and HIV-1 restrictionA new approach to establish a cell line with reduced risk of endogenous retroviruses.Viral Restriction Activity of Feline BST2 Is Independent of Its N-Glycosylation and Induction of NF-κB Activation.Viral and cellular requirements for the budding of feline endogenous retrovirus RD-114.Feline tetherin is characterized by a short N-terminal region and is counteracted by the feline immunodeficiency virus envelope glycoprotein.Refrex-1, a soluble restriction factor against feline endogenous and exogenous retrovirusesEquine tetherin blocks retrovirus release and its activity is antagonized by equine infectious anemia virus envelope protein.Cellular restriction factors of feline immunodeficiency virus.Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.Inhibition of budding/release of porcine endogenous retrovirus.The effect of bovine BST2A1 on the release and cell-to-cell transmission of retroviruses.A Naturally Occurring Domestic Cat APOBEC3 Variant Confers Resistance to Feline Immunodeficiency Virus Infection.High-Mannose But Not Complex-Type Glycosylation of Tetherin Is Required for Restriction of HIV-1 Release.Prospects in Innate Immune Responses as Potential Control Strategies against Non-Primate Lentiviruses
P2860
Q28730708-129A18F1-AA21-4FF5-9449-BE1D44C9B2E4Q31086787-66208218-F340-4629-A0D7-C42423AE4A1AQ34123690-CA5C8B65-7D40-4CC5-A755-27227FC15285Q34408687-C01AAA15-3F3B-4397-837F-C9D334172155Q34668033-A91771E5-0A50-441F-8221-D5916BAA44DBQ35778560-A57BCA68-6FF3-4B73-AD14-5A65370AC15AQ35781529-868E6102-2E28-4A1E-B6EC-AD7DAD742F66Q36086707-8DA70BFF-DFA2-43EC-A20A-EA7710486F26Q37254358-2F090ADF-661B-47F6-9309-4B4FE27D1247Q37547504-7C2CDBFB-A842-4EAC-AD04-96CD3D68FB94Q37954259-08677B74-EDC6-45E7-B91F-5C13F9ECAF25Q38326209-7198BD1C-D926-4142-B39B-FC83E58DF0BEQ38984528-4B9E807C-CA08-451B-8659-4D178540DC20Q40055431-2E41AE8D-8085-467C-B290-B620CC6BE9ECQ40941381-BE41AE4D-28B5-480E-89CC-0A13E050F645Q47230024-13820002-06F5-4205-A5BA-77FE3C9C50ECQ56977004-9E124D73-A7B9-49D9-8D4D-5E293C7032D5
P2860
Cloning and characterization of the antiviral activity of feline Tetherin/BST-2
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cloning and characterization of the antiviral activity of feline Tetherin/BST-2
@ast
Cloning and characterization of the antiviral activity of feline Tetherin/BST-2
@en
type
label
Cloning and characterization of the antiviral activity of feline Tetherin/BST-2
@ast
Cloning and characterization of the antiviral activity of feline Tetherin/BST-2
@en
prefLabel
Cloning and characterization of the antiviral activity of feline Tetherin/BST-2
@ast
Cloning and characterization of the antiviral activity of feline Tetherin/BST-2
@en
P2093
P2860
P1433
P1476
Cloning and characterization of the antiviral activity of feline Tetherin/BST-2
@en
P2093
Aiko Fukuma
Jiro Yasuda
Masumi Abe
Takayuki Miyazawa
Yuko Morikawa
P2860
P304
P356
10.1371/JOURNAL.PONE.0018247
P407
P577
2011-03-29T00:00:00Z